RVMD logo

Revolution Medicines, Inc. (RVMD) Selling, General & Administrative Expenses

Annual SG&A:

$97.30M+$21.68M(+28.67%)
December 31, 2024

Summary

  • As of today, RVMD annual SG&A is $97.30 million, with the most recent change of +$21.68 million (+28.67%) on December 31, 2024.
  • During the last 3 years, RVMD annual SG&A has risen by +$66.85 million (+219.54%).
  • RVMD annual SG&A is now at all-time high.

Performance

RVMD SG&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRVMDincome statement metrics

Quarterly SG&A:

$0.00-$40.58M(-100.00%)
September 30, 2025

Summary

  • As of today, RVMD quarterly SG&A is $0.00, with the most recent change of -$40.58 million (-100.00%) on September 30, 2025.
  • Over the past year, RVMD quarterly SG&A has dropped by -$23.96 million (-100.00%).
  • RVMD quarterly SG&A is now -100.00% below its all-time high of $40.58 million, reached on June 30, 2025.

Performance

RVMD Quarterly SG&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRVMDincome statement metrics

TTM SG&A:

-$8.39B-$960.98M(-12.93%)
September 30, 2025

Summary

  • As of today, RVMD TTM SG&A is -$8.39 billion, with the most recent change of -$960.98 million (-12.93%) on September 30, 2025.
  • Over the past year, RVMD TTM SG&A has dropped by -$8.49 billion (-8429.51%).
  • RVMD TTM SG&A is now -7548.63% below its all-time high of -$109.72 million.

Performance

RVMD TTM SG&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRVMDincome statement metrics

Selling, General & Administrative Expenses Formula

SG&A = Total Operating Expenses - Cost of Goods Sold - Research & Development

RVMD Selling, General & Administrative Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+28.7%-100.0%-8429.5%
3Y3 Years+219.5%-100.0%-10000.0%
5Y5 Years+684.3%-100.0%-10000.0%

RVMD Selling, General & Administrative Expenses Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+219.5%-100.0%at low-285.1%at low
5Y5-Yearat high+684.3%-100.0%at low-990.3%at low
All-TimeAll-Timeat high+2041.7%-100.0%at low-7548.6%at low

RVMD Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
Sep 2025
-
$0.00(-100.0%)
$103.81M(-18.8%)
Jun 2025
-
$40.58M(+15.9%)
$127.77M(+17.3%)
Mar 2025
-
$35.01M(+24.1%)
$108.90M(+12.6%)
Dec 2024
$97.30M(+28.7%)
$28.21M(+17.8%)
$96.72M(-4.0%)
Sep 2024
-
$23.96M(+10.4%)
$100.75M(+9.2%)
Jun 2024
-
$21.71M(-4.9%)
$92.31M(+8.3%)
Mar 2024
-
$22.84M(-29.2%)
$85.23M(+12.7%)
Dec 2023
$75.62M(+86.3%)
$32.24M(+107.9%)
$75.62M(+39.3%)
Sep 2023
-
$15.51M(+6.0%)
$54.29M(+10.3%)
Jun 2023
-
$14.64M(+10.7%)
$49.21M(+9.9%)
Mar 2023
-
$13.22M(+21.2%)
$44.77M(+10.3%)
Dec 2022
$40.59M
$10.91M(+4.6%)
$40.59M(+5.8%)
Sep 2022
-
$10.43M(+2.3%)
$38.37M(+7.4%)
Jun 2022
-
$10.20M(+12.9%)
$35.72M(+8.9%)
DateAnnualQuarterlyTTM
Mar 2022
-
$9.04M(+4.0%)
$32.82M(+7.8%)
Dec 2021
$30.45M(+42.1%)
$8.69M(+11.6%)
$30.45M(+10.4%)
Sep 2021
-
$7.79M(+6.8%)
$27.58M(+9.7%)
Jun 2021
-
$7.30M(+9.4%)
$25.13M(+9.6%)
Mar 2021
-
$6.67M(+14.5%)
$22.93M(+7.0%)
Dec 2020
$21.43M(+72.7%)
$5.83M(+9.1%)
$21.43M(+8.4%)
Sep 2020
-
$5.34M(+4.9%)
$19.77M(+12.8%)
Jun 2020
-
$5.09M(-1.5%)
$17.53M(+15.6%)
Mar 2020
-
$5.17M(+24.2%)
$15.16M(+22.2%)
Dec 2019
$12.41M(+31.8%)
$4.16M(+34.1%)
$12.41M(+2.7%)
Sep 2019
-
$3.10M(+13.9%)
$12.08M(+34.6%)
Jun 2019
-
$2.73M(+12.8%)
$8.98M(+43.6%)
Mar 2019
-
$2.42M(-37.0%)
$6.25M(+63.0%)
Dec 2018
$9.41M(+107.1%)
$3.83M
$3.83M
Dec 2017
$4.54M
-
-

FAQ

  • What is Revolution Medicines, Inc. annual SG&A?
  • What is the all-time high annual SG&A for Revolution Medicines, Inc.?
  • What is Revolution Medicines, Inc. annual SG&A year-on-year change?
  • What is Revolution Medicines, Inc. quarterly SG&A?
  • What is the all-time high quarterly SG&A for Revolution Medicines, Inc.?
  • What is Revolution Medicines, Inc. quarterly SG&A year-on-year change?
  • What is Revolution Medicines, Inc. TTM SG&A?
  • What is the all-time high TTM SG&A for Revolution Medicines, Inc.?
  • What is Revolution Medicines, Inc. TTM SG&A year-on-year change?

What is Revolution Medicines, Inc. annual SG&A?

The current annual SG&A of RVMD is $97.30M

What is the all-time high annual SG&A for Revolution Medicines, Inc.?

Revolution Medicines, Inc. all-time high annual SG&A is $97.30M

What is Revolution Medicines, Inc. annual SG&A year-on-year change?

Over the past year, RVMD annual SG&A has changed by +$21.68M (+28.67%)

What is Revolution Medicines, Inc. quarterly SG&A?

The current quarterly SG&A of RVMD is $0.00

What is the all-time high quarterly SG&A for Revolution Medicines, Inc.?

Revolution Medicines, Inc. all-time high quarterly SG&A is $40.58M

What is Revolution Medicines, Inc. quarterly SG&A year-on-year change?

Over the past year, RVMD quarterly SG&A has changed by -$23.96M (-100.00%)

What is Revolution Medicines, Inc. TTM SG&A?

The current TTM SG&A of RVMD is -$8.39B

What is the all-time high TTM SG&A for Revolution Medicines, Inc.?

Revolution Medicines, Inc. all-time high TTM SG&A is -$109.72M

What is Revolution Medicines, Inc. TTM SG&A year-on-year change?

Over the past year, RVMD TTM SG&A has changed by -$8.49B (-8429.51%)
On this page